Literature DB >> 25423015

Obese first-degree relatives of patients with type 2 diabetes with elevated triglyceride levels exhibit increased β-cell function.

Enrique Torres-Rasgado1, Leonardo M Porchia, Guadalupe Ruiz-Vivanco, M Elba Gonzalez-Mejia, Blanca G Báez-Duarte, Patricia Pulido-Pérez, Alicia Rivera, Jose R Romero, Ricardo Pérez-Fuentes.   

Abstract

BACKGROUND: Type 2 diabetes mellitus (T2DM) is characterized as a disease continuum that is marked by metabolic changes that are present for several years, sometimes well before frank diagnosis of T2DM. Genetic predisposition, ethnicity, geography, alterations in BMI, and lipid profile are considered important markers for the pathogenesis of T2DM through mechanisms that remain unresolved and controversial. The aim of this study was to investigate the relationship between triglycerides (TGs) and β-cell function, insulin resistance (IR), and insulin sensitivity (IS) in obese first-degree relatives of patients with T2DM (FDR-T2DM) among subjects from central Mexico with normal glucose tolerance (NGT).
METHODS: We studied 372 FDR-T2DM subjects (ages,18-65) and determined body mass index (BMI), fasting plasma glucose (FPG), oral glucose tolerance test (OGTT), insulin, and TGs levels. Subjects were categorized based on glycemic control [NGT, prediabetes (PT2DM), or T2DM]. NGT subjects were further categorized by BMI [normal weight (Ob-) or obese (Ob+)] and TGs levels (TG-, <150 mg/dL, or TG+, ≥150 mg/dL). β-cell function, IR, and IS were determined by the homeostasis model assessment of β-cell function (HOMA2-β), homeostasis model assessment of insulin resistance (HOMA2-IR), and Quantitative Insulin Sensitivity Check Index (QUICKI) indices, respectively.
RESULTS: The obese subjects with elevated TGs levels had 21%-60% increased β-cell function when compared to all groups (P<0.05). In addition, this group had insulin levels, IS, and IR similar to PT2DM. Furthermore, only in obese subjects did TGs correlate with β-cell function (ρ=0.502, P<0.001).
CONCLUSION: We characterized FDR-T2DM subjects from central Mexico with NGT and revealed a class of obese subjects with elevated TGs and β-cell function, which may precede PT2DM.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25423015      PMCID: PMC4361158          DOI: 10.1089/met.2014.0095

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  43 in total

1.  Distinctive postprandial modulation of beta cell function and insulin sensitivity by dietary fats: monounsaturated compared with saturated fatty acids.

Authors:  Sergio López; Beatriz Bermúdez; Yolanda M Pacheco; José Villar; Rocío Abia; Francisco J G Muriana
Journal:  Am J Clin Nutr       Date:  2008-09       Impact factor: 7.045

Review 2.  Triglyceride is the major atherogenic lipid in NIDDM.

Authors:  M R Taskinen
Journal:  Diabetes Metab Rev       Date:  1997-06

3.  Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention.

Authors:  Jirí Hrebícek; Vladimír Janout; Jana Malincíková; Dagmar Horáková; Ludek Cízek
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

4.  Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance--a population-based twin study.

Authors:  P Poulsen; K O Kyvik; A Vaag; H Beck-Nielsen
Journal:  Diabetologia       Date:  1999-02       Impact factor: 10.122

5.  Diabetes in South and Central America: an update.

Authors:  Pablo Aschner; Carlos Aguilar-Salinas; Loreto Aguirre; Laercio Franco; Juan Jose Gagliardino; Sylvia Gorban de Lapertosa; Segundo Seclen; Mary Vinocour
Journal:  Diabetes Res Clin Pract       Date:  2013-12-01       Impact factor: 5.602

Review 6.  The prevalence of metabolic syndrome in children: a systematic review of the literature.

Authors:  Amanda Friend; Leone Craig; Steve Turner
Journal:  Metab Syndr Relat Disord       Date:  2012-12-18       Impact factor: 1.894

Review 7.  Triglycerides and atherogenic lipoproteins: rationale for lipid management.

Authors:  R M Krauss
Journal:  Am J Med       Date:  1998-07-06       Impact factor: 4.965

8.  Triglycerides in clinical medicine. A review.

Authors:  M Tzagournis
Journal:  Am J Clin Nutr       Date:  1978-08       Impact factor: 7.045

Review 9.  Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and Beta-cell dysfunction on micro- and macrovascular complications.

Authors:  Gianluca Bardini; Carlo M Rotella; Stefano Giannini
Journal:  Rev Diabet Stud       Date:  2012-11-15

10.  Relationship between blood lipid profiles and pancreatic islet β cell function in Chinese men and women with normal glucose tolerance: a cross-sectional study.

Authors:  Tianpeng Zheng; Yun Gao; Haoming Tian
Journal:  BMC Public Health       Date:  2012-08-10       Impact factor: 3.295

View more
  1 in total

1.  Impact of triglycerides and waist circumference on insulin resistance and β-cell function in non-diabetic first-degree relatives of type 2 diabetes.

Authors:  Fahd Ahmed; Molham Al-Habori; Ebtesam Al-Zabedi; Riyadh Saif-Ali
Journal:  BMC Endocr Disord       Date:  2021-06-16       Impact factor: 2.763

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.